Results 21 to 30 of about 12,800 (198)

Efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder and nocturia, current clinical features and outcomes: A systematic review

open access: yesAsian Journal of Urology, 2022
Objective: To evaluate the efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder (OAB) and nocturia.
Bara Barakat   +4 more
doaj   +1 more source

A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial [PDF]

open access: yesInternational Brazilian Journal of Urology, 2020
Introduction: Nocturnal enuresis (enuresis) is one of the most common developmental problems of childhood, which has often a familial basis, causes mental and psychological damage to the child and disrupts family solace.
Parvin Mousavi Ghanavati   +2 more
doaj   +1 more source

Predicting the Need for Desmopressin Treatment During Inpatient and After Discharge Following Endoscopic Sellar Surgery

open access: yesFrontiers in Neurology, 2022
IntroductionPostoperative diabetes insipidus (DI) is a common complication following endoscopic sellar surgery. However, the requirement of desmopressin treatment for patients with DI are heterogenous.
Chia-En Wong   +10 more
doaj   +1 more source

Korean guideline of desmopressin for the treatment of nocturia in men [PDF]

open access: yesInvestigative and Clinical Urology, 2022
Purpose: Nocturia is the most bothersome of lower urinary tract symptoms in men. Desmopressin, a synthetic analog of the human hormone vasopressin, has been used for the treatment of nocturia.
Eu Chang Hwang   +9 more
doaj   +1 more source

Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study

open access: yesDrug and Alcohol Dependence Reports, 2023
Background: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder.
Wilfrid Noël Raby   +8 more
doaj   +1 more source

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone

open access: yesJournal of Veterinary Internal Medicine, 2021
Background Glucocorticoids are used for a variety of purposes in veterinary medicine but often are associated with clinically important adverse effects. Polyuria and polydipsia are the most frustrating adverse effects noted by owners.
Pamela Galati   +5 more
doaj   +1 more source

Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review [PDF]

open access: yes, 2013
OBJECTIVE: Dilutional hyponatremia is a serious adverse effect of desmopressin, a vasopressin analog that is widely prescribed to manage monosymptomatic enuresis.
Bianchetti, Mario G   +11 more
core   +2 more sources

Desmopressin in combination with anticholinergic agents in the treatment of nocturnal enuresis: a systematic review and meta-analysis

open access: yesFrontiers in Pediatrics, 2023
BackgroundThe desmopressin combined with anticholinergic agents for the treatment of nocturnal enuresis (NE) remains controversial. This meta-analysis assesses the efficacy and safety of desmopressin compared with desmopressin plus anticholinergic agents
Tong Cai, Yi Yao, Weigui Sun, Peipei Lei
doaj   +1 more source

Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis [PDF]

open access: yes, 2016
Most patients with monosymptomatic nocturnal enuresis can be effectively treated with an enuresis alarm or antidiuretic therapy (desmopressin), depending on the pathophysiology of the condition in the individual patient.
Vande Walle, Johan   +7 more
core   +2 more sources

Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease

open access: yesEndocrine Connections, 2017
Recurrence of Cushing’s disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence.
Alberto Giacinto Ambrogio   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy